How is the Aytu BioPharma Inc today?

The Aytu BioPharma Inc today is trading in the green, up by 1.02% at 1.98.

What is Aytu BioPharma Inc Annual Revenue?

Aytu BioPharma Inc Annual Revenue fell 24.58%, in the last year to $81 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Aytu BioPharma Inc Annual Net Profit?

Aytu BioPharma Inc Annual Net Profit rose 7.08% in the last year to $15.84 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Aytu BioPharma Inc Price to Earning Ratio?

Aytu BioPharma Inc Price to Earning Ratio is 7.45, higher than its sector PE ratio of 4.28.

What is Aytu BioPharma Inc Stock Price?

Aytu BioPharma Inc Stock Price fell 38.12% and underperformed its sector by 57.45% in the past year.

What is Aytu BioPharma Inc Quarterly Revenue?

Aytu BioPharma Inc Quarterly Revenue rose 31.57% YoY to $18.45 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Aytu BioPharma Inc Quarterly Net profit?

Aytu BioPharma Inc Quarterly Net profit rose 238.34% YoY to $3.99 M. Its sector's average net profit growth YoY for the quarter was -213.06%.

What is Aytu BioPharma Inc Debt to Equity Ratio?

Aytu BioPharma Inc Debt to Equity Ratio of 0.55 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Aytu BioPharma Inc Return on Equity(ROE)?

Aytu BioPharma Inc Return on Equity(ROE) for the last financial year was -47.24%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Aytu BioPharma Inc Mutual Fund Holding?

Aytu BioPharma Inc Mutual Fund Holding increased by 0.01% in the last quarter to 2.09.

What is Aytu BioPharma Inc Promoter Share Holding?

Aytu BioPharma Inc Promoter Share Holding increased by 0.05% in the most recent quarter to 1.42%.

What is Aytu BioPharma Inc Interest Coverage Ratio?

Aytu BioPharma Inc Interest Coverage Ratio is -1.94, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Aytu BioPharma Inc Institutional Holding?

Aytu BioPharma Inc Institutional Holding decreased by 0.24% in the last quarter to 30.01.

Aytu BioPharma Inc XNAS: AYTU

Aytu BioPharma Inc Live Share Price Today, Share Analysis and Chart

Name: Aytu BioPharma Inc: Is Infosys Ltd. worth buying?
Item: Aytu BioPharma Inc
Rating: 3.13425
Author: Trendlyne DVM scores

about

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other commo...

1.98 0.02 (1.02%)

38.70% Fall from 52W High

181.5K XNAS Volume

XNAS 27 May, 2025 5:30 PM (EDT)

Not Eligible

-

Affordable Valuation

66.5 / 100

Technically Neutral

58.9 / 100

8

1Yr Price target upside is 304%

1 analysts

Aytu BioPharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aytu BioPharma Inc FAQ

How is Aytu BioPharma Inc today?

Aytu BioPharma Inc today is trading in the green, and is up by 1.02% at 1.98.

How has Aytu BioPharma Inc performed historically?

Aytu BioPharma Inc is currently trading up 1.02% on an intraday basis. In the past week the stock fell -2.46%. stock has been up 58.40% in the past quarter and fell -38.12% in the past year. You can view this in the overview section.